Conference abstract
A targeted drug delivery nanosystem to hepatocellular carcinoma
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Hepatocellular Carcinoma (HCC) is one of the most frequent cause of cancer-related mortality worldwide. Combination of different chemotherapeutics drugs may offer advantages for the treatment of HCC. Nanotechnology has made exceptional headway, emerging as a revolutionary platform to treat a wide variety of tumors, mainly due to prolonged drug release, as well as increased cell internalization. In this work, we have developed a drug delivery system, a hybrid nanoparticle formulation, which allows the specific delivery into HCC cells. The hybrid nanoparticle comprises a core of PLGA coated by a lipidic envelope constituted by 1-palmitoyl- 2-oleoyl-sn-glycero-3-phosphocholine; cholesterol and 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N- [methoxy(polyethylene glycol)-2000] (PEG) with a specific ligand (GalNac) covalently attached. The obtained nanosystems were characterized by transmission electron microscopy, dynamic light scattering, zeta potential analysis and differential scanning calorimetry, showing a mean diameter (150 nm) and a surface charge ( -25 mv) suitable for in vivo applications. The hybrid nanoparticle enables the release of two drugs demonstrated through release studies of fluorescent probes and drugs in dialysis. The presence of GalNac (a specific ligand to the asialoglycoprotein receptor that is overexpressed in HCC) allowed the internalization of the nanosystems and the release of the drugs preferentially in HCC cells, as demonstrated by flow cytometry and confocal microscopy. This new nanosystem represents an added value in the fight against the global scourge of hepatocellular carcinoma.
Keywords
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalAmerican Journal of Advanced Drug Delivery
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Henrique Faneca”
- BylineArticles whose byline prints “Dina Farinha”